Felbamate Suspension
Product Images NDC 70954-051

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Felbamate (NDC 70954-051). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novitium Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label1 (Felb 237)

This is a prescription medication with the NDC 70954-051-10, intended for oral consumption as an oral suspension. The full prescribing information can be found in the accompanying package insert. It is manufactured by Novitium Pharma LLC and should be stored at a temperature between 20°C to 25°C. The medication guide must be dispensed to each patient, and the suspension should be stored in a tight container. This medication has 120 mg per 5 mi dosage strength, and one must shake the bottle well before each use. Issued in May 2022.*

FDA Label Image

Label2 (Felb 473)

This is a prescription medication in the form of an oral suspension containing Felbamate USP. Each 5 mL contains 120 mg per mL of the active ingredient. It is manufactured by Novitium Pharma LLC and must be dispensed in a tight container. It is important to shake the bottle well before each use. Full prescribing information can be found in the accompanying package insert. The medication guide should be given to the patient. It must be stored between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). The product has a shelf life until May 2022.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.